| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/08/2007 | US20070032445 Antisense IAP nucleobase oligomers and uses thereof |
| 02/08/2007 | US20070032439 Tarp promoter and uses thereof |
| 02/08/2007 | US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 02/08/2007 | US20070032417 Peptides and therapeutic uses thereof |
| 02/08/2007 | US20070032411 Protein kinase signalling |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031511 Method of treatment |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | US20070031480 Enhanced delivery of sphingolipids |
| 02/08/2007 | US20070031442 Method and compositions for boosting immune response |
| 02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 02/08/2007 | US20070031434 Uses for Eph receptor antagonists and agonists |
| 02/08/2007 | US20070031433 Tumor antigen |
| 02/08/2007 | US20070031432 Tumor antigen |
| 02/08/2007 | US20070031431 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 02/08/2007 | US20070031430 Varible domain of heavy chain antibodies; antitumor agents |
| 02/08/2007 | US20070031421 Inhibitors targeting osteoclast-associated protein |
| 02/08/2007 | US20070031415 Regulation of interaction between rapl and rap1 |
| 02/08/2007 | US20070031413 Treatment with anti-vegf antibodies |
| 02/08/2007 | US20070031383 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 02/08/2007 | US20070031379 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same |
| 02/08/2007 | US20070031374 Treating cell proliferative disorders via administration of mixture comprising interleukin-21 and anti-cancer monoclonal antibody |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/08/2007 | DE102005036655A1 Behandlung von Tumoren mit IKK-ß Inhibitoren Treatment of tumors with IKK-ß inhibitors |
| 02/08/2007 | DE102005036542A1 CTL-Prodrug CTL prodrug |
| 02/08/2007 | CA2620937A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2618044A1 Antibodies directed against a ldl receptor |
| 02/08/2007 | CA2617692A1 Combinations containing ikk-.beta. inhibitors |
| 02/08/2007 | CA2617690A1 Treatment of tumours with ikk-.beta. inhibitors |
| 02/08/2007 | CA2617462A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617458A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617454A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617447A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617446A1 Cancerous disease modifying antibodies |
| 02/08/2007 | CA2617256A1 Cyclic amine compound |
| 02/08/2007 | CA2617150A1 Use of chk2 kinase inhibitors for cancer treatment |
| 02/08/2007 | CA2617009A1 Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune response |
| 02/08/2007 | CA2616987A1 Mutated pseudomonas exotoxins with reduced antigenicity |
| 02/08/2007 | CA2616898A1 Cd33-specific single-chain immunotoxin and method of use |
| 02/08/2007 | CA2616677A1 Cathepsin k inhibitors |
| 02/08/2007 | CA2616669A1 Squaric acid derivatives_ii |
| 02/08/2007 | CA2616159A1 Benzimidazoles useful as inhibitors of protein kinases |
| 02/08/2007 | CA2615669A1 Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 02/08/2007 | CA2615592A1 Antitumoral compounds |
| 02/08/2007 | CA2615574A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/08/2007 | CA2614334A1 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 02/08/2007 | CA2614157A1 Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
| 02/08/2007 | CA2613518A1 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
| 02/08/2007 | CA2613366A1 Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators |
| 02/08/2007 | CA2613327A1 Method of treating patients with a mucinous glycoprotein (muc-1) vaccine |
| 02/08/2007 | CA2609441A1 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 02/07/2007 | EP1749884A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 02/07/2007 | EP1749831A1 Demethyl-cantharidin platinum complex isomers and their use |
| 02/07/2007 | EP1749830A1 Curcumol derivatives, the compositions comprising the same and the use of the same in the manufacture of medicament |
| 02/07/2007 | EP1749827A1 Anti-tumor agent |
| 02/07/2007 | EP1749822A1 Novel cysteine protease inhibitors and their therapeutic applications |
| 02/07/2007 | EP1749819A1 (rac)-N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazole-3-carboxamide hydrates |
| 02/07/2007 | EP1749540A2 Compositions for improving bioavailability of orally administered drugs |
| 02/07/2007 | EP1749529A1 Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases |
| 02/07/2007 | EP1749520A1 Water-dispersible encapsulated sterols |
| 02/07/2007 | EP1749027A2 Gene products expressed differentially in tumors and use thereof |
| 02/07/2007 | EP1748792A1 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same |
| 02/07/2007 | EP1748775A1 Pharmaceutical products for treating neoplastic disease and inflammation |
| 02/07/2007 | EP1748767A1 Diarylalkanes as potent inhibitors of binuclear enzymes |
| 02/07/2007 | EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase |
| 02/07/2007 | EP1501504B1 1-substituted imidazole derivatives as nos inhibitors |
| 02/07/2007 | EP1315501B1 Alpha v integrin receptor antagonists |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 02/07/2007 | EP0971748B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 02/07/2007 | CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 02/07/2007 | CN1910153A Derivatives of pyridine and quinoline |
| 02/07/2007 | CN1910150A Piperidine derivatives as GCS inhibitors |
| 02/07/2007 | CN1909927A Method of suppressing cancer |
| 02/07/2007 | CN1908187A Application of protein arginine methyl transferase 5 in cell detection and treatment of leukemia |
| 02/07/2007 | CN1908182A Preparation for amylovorin of bacillus and application thereof |
| 02/07/2007 | CN1908015A Stabilized small molecule polypeptide capable of inhibiting HER2 high expression tumour cell proliferation |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/07/2007 | CN1907989A Setoglaucine salt, preparation method thereof and medicinal composition containing the same |
| 02/07/2007 | CN1907985A N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof |
| 02/07/2007 | CN1907970A Method for synthesizing heteroaryl thiosemicarbazone antineoplastic |
| 02/07/2007 | CN1907494A Polybutylcyanoacrylate nano-granule with resolubity, its application and use thereof |
| 02/07/2007 | CN1907493A Ad5F35-LMP2 recombinant adenovirus vaccine comprising Epstein-Barr virus latent membrane protein 2 gene |
| 02/07/2007 | CN1907492A Application of GTP enzyme in antineoplastic preparing process |
| 02/07/2007 | CN1907457A Chinese herbal medicinal composition for treating leukemia and preparation method thereof |
| 02/07/2007 | CN1907433A Process for extracting physiologically active substance from highland barley tender leaf |
| 02/07/2007 | CN1907382A Application of nightblooming cestrum and extract thereof with antineoplastic function |
| 02/07/2007 | CN1907325A Effective part of traditional Chinese medicine ground bamboo shoot for antineoplastic and oxidation resistance function, their preparing process and application |
| 02/07/2007 | CN1907312A Use of centipeda volatile oil in preparation of tumor growth and proliferation inhibitor |
| 02/07/2007 | CN1907310A Pharmaceutical composition and its preparation |
| 02/07/2007 | CN1907308A Chinese traditional medicine composition for treating tumour |
| 02/07/2007 | CN1907304A Process for removing toxic component from oleum fructus bruceae |
| 02/07/2007 | CN1907303A Refining ganoderam lucidum spore oil and method for preparing same |
| 02/07/2007 | CN1907301A Health care oral liquid of phellinus igniarius and its preparing method |
| 02/07/2007 | CN1907286A Injectio for nanometer marsdenia tenacissima aglycone and its preparing method |
| 02/07/2007 | CN1907284A Pharmaceutical composition containing pemetrexed |
| 02/07/2007 | CN1907283A Application of kuianchun family compound in anti-tumor drug preparing process |